Cal-Maine Foods reported second-quarter earnings of $2.13 per share, outperforming analyst projections of $2.01, while its top-line fell short at $769.5 million versus expectations of $826.4 million. The 19% year-over-year revenue decline reflected steep drops in conventional egg volumes and prices, even as the company delivered profitability above forecast. Gross margin held at roughly 43.5%, supported by cost efficiencies across feed and distribution.

Specialty egg sales—organic, free-range and cage-free varieties—rose mid-single digits in volume and maintained premium per-dozen realizations, offsetting part of the weakness in the conventional segment, which saw a 41% collapse in revenues due to plummeting commodity egg prices. CEO Sherman Miller emphasized that specialty prices averaged $2.10 per dozen in Q2, compared with $1.20 per dozen for conventional eggs, underscoring the resilience of branded product lines during price normalization from 2025’s historic highs.

Analysts forecast full-year earnings to decline from nearly $25 per share in 2025 to about $9.31 in 2026, with a potential drop to $6.67 by 2028 under downside scenarios. At these levels, Cal-Maine trades near 11.5 times 2028 earnings estimates, a multiple roughly in line with its 11% dividend yield. The company’s strong balance sheet—with zero long-term debt—and a current ratio above 6.8x provides room to sustain the quarterly dividend, which has increased year-over-year on healthy cash flow generation.